Contrast-enhanced ultrasound (CEUS) appearance of hepatic myelolipoma

Guido Menozzi1, Valeria Maccabruni2, Giulia Marini1

  • 1Infectious Diseases Department, Azienda Ospedaliera S.Maria Nuova-IRCCS, Reggio Emilia, Italy.

Journal of Ultrasound
|March 5, 2016
PubMed

Insights

This case report details a rare hepatic myelolipoma in a 72-year-old female. Contrast-enhanced ultrasound (CEUS) showed features typical of benign tumors, aiding differential diagnosis.

Area of Science:

  • Hepatology
  • Radiology
  • Oncology

Background:

  • Hepatic myelolipomas are rare, benign liver tumors.
  • Accurate diagnosis is crucial for differentiating benign from malignant liver lesions.

Observation:

  • A case report of a 72-year-old female with a hepatic myelolipoma is presented.
  • The lesion was previously identified as hyperechoic on conventional sonography.
  • Contrast-enhanced ultrasound (CEUS) was utilized for detailed evaluation.

Findings:

  • CEUS revealed homogeneous hyperenhancement in the arterial phase.
  • A slight hyperenhancement was noted in the portal venous phase.
  • These CEUS features are characteristic of benign hepatic tumors.

Implications:

  • CEUS can assist in the differential diagnosis of liver lesions.
  • Distinguishing benign from malignant hepatic tumors is essential.
  • Histopathological evaluation via biopsy remains the definitive diagnostic method.